| 1 | [SID56463691] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 2 | [SID56463691] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 3 | [SID56463691] | Active | Potency | 11.2202 | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a [AID493170, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a | | AID | 493170 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 4 | [SID56463691] | Active | Potency | 11.2202 | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a [AID493170, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a | | AID | 493170 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 5 | [SID56463691] | Active | Potency | 11.6891 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 11.6891 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID56463691] | Active | Potency | 26.8545 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 26.8545 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 7 | [SID56463691] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 8 | [SID56463691] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 9 | [SID56463691] | Active | Potency | 70.7946 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 10 | [SID56463691] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 11 | [SID56463691] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 12 | [SID56463691] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 13 | [SID56463691] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 14 | [SID56463691] | Active | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 15 | [SID56463691] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 16 | [SID56463691] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 17 | [SID56463691] | Active | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 18 | [SID56463691] | Active | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 19 | [SID56463691] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 20 | [SID56463691] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID493034, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 493034 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 21 | [SID56463691] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 22 | [SID56463691] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 23 | [SID56463691] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 24 | [SID56463691] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 25 | [SID56463691] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 26 | [SID56463691] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 27 | [SID56463691] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID56463691] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID56463691] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID56463691] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 31 | [SID56463691] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 32 | [SID56463691] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 33 | [SID56463691] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 34 | [SID56463691] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 35 | [SID56463691] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 36 | [SID56463691] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 37 | [SID56463691] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 38 | [SID56463691] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 39 | [SID56463691] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers [AID493056, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers | | AID | 493056 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 40 | [SID56463691] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. [AID493084, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. | | AID | 493084 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 41 | [SID56463691] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 42 | [SID56463691] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 43 | [SID56463691] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast [AID2825, Type: screening] | NLRP3 protein [Homo sapiens] [gi:219518789] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast | | AID | 2825 | | BioAssay type | screening | | Target | NLRP3 protein [Homo sapiens] [gi:219518789] | | PubMed | | | Data Table |  |
|
| 44 | [SID56463691] | Inactive | | | HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8) [AID2540, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8) | | AID | 2540 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 45 | [SID56463691] | Inactive | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463691] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463691] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463691] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463691] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 50 | [SID56463691] | Inactive | | | High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity [AID651819, Type: screening] | TRIC [Homo sapiens] [gi:83758679] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56463691 | | CID | 25102716 | | Outcome | Inactive | | BioAssay | High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity | | AID | 651819 | | BioAssay type | screening | | Target | TRIC [Homo sapiens] [gi:83758679] | | PubMed | | | Data Table |  |
|